Organogenesis Holdings Inc. (ORGO)
USD 4.2
(11.87%)
USD 4.2
(11.87%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 314.13 Million USD | -9.3% |
| 2022 | 323.57 Million USD | 15.17% |
| 2021 | 280.94 Million USD | 25.67% |
| 2020 | 223.56 Million USD | 4.23% |
| 2019 | 214.49 Million USD | 24.2% |
| 2018 | 172.7 Million USD | 3661.09% |
| 2017 | 4.59 Million USD | 2100.23% |
| 2016 | 208.69 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 87.72 Million USD | 13.08% |
| 2024 Q1 | 81.47 Million USD | 21.36% |
| 2023 Q1 | 85.03 Million USD | 6.71% |
| 2023 FY | 293.46 Million USD | -9.3% |
| 2023 Q4 | 67.13 Million USD | -10.12% |
| 2023 Q3 | 74.69 Million USD | -8.08% |
| 2023 Q2 | 81.25 Million USD | -4.45% |
| 2022 Q2 | 82.81 Million USD | 14.76% |
| 2022 Q1 | 72.16 Million USD | -4.43% |
| 2022 FY | 323.57 Million USD | 15.17% |
| 2022 Q4 | 79.68 Million USD | -10.37% |
| 2022 Q3 | 88.9 Million USD | 7.35% |
| 2021 Q2 | 69.66 Million USD | 8.11% |
| 2021 FY | 280.94 Million USD | 25.67% |
| 2021 Q1 | 64.44 Million USD | 8.28% |
| 2021 Q4 | 75.51 Million USD | 5.87% |
| 2021 Q3 | 71.32 Million USD | 2.37% |
| 2020 Q2 | 51.17 Million USD | -11.81% |
| 2020 FY | 223.56 Million USD | 4.23% |
| 2020 Q4 | 59.51 Million USD | 8.5% |
| 2020 Q3 | 54.85 Million USD | 7.2% |
| 2020 Q1 | 58.02 Million USD | 3.6% |
| 2019 Q1 | 52.26 Million USD | 3.35% |
| 2019 FY | 214.49 Million USD | 24.2% |
| 2019 Q4 | 56 Million USD | 4.89% |
| 2019 Q3 | 53.39 Million USD | 1.09% |
| 2019 Q2 | 52.82 Million USD | 1.07% |
| 2018 Q3 | 5.72 Million USD | 0.0% |
| 2018 Q4 | 50.56 Million USD | 783.8% |
| 2018 FY | 172.7 Million USD | 3661.09% |
| 2018 Q1 | - USD | -100.0% |
| 2018 Q2 | - USD | 0.0% |
| 2017 Q2 | 221.8 Thousand USD | 1.45% |
| 2017 Q3 | 2.85 Million USD | 1186.31% |
| 2017 FY | 4.59 Million USD | 2100.23% |
| 2017 Q4 | 1.29 Million USD | -54.5% |
| 2017 Q1 | 218.64 Thousand USD | 22.73% |
| 2016 FY | 208.69 Thousand USD | 0.0% |
| 2016 Q2 | 500.00 USD | -96.78% |
| 2016 Q4 | 178.15 Thousand USD | 1129.34% |
| 2016 Q3 | 14.49 Thousand USD | 2798.4% |
| 2016 Q1 | 15.55 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Bright Green Corporation | 8.25 Million USD | -3706.36% |
| Alpha Teknova, Inc. | 45.85 Million USD | -585.0% |
| ANI Pharmaceuticals, Inc. | 195.98 Million USD | -60.286% |
| Aquestive Therapeutics, Inc. | 44.85 Million USD | -600.348% |
| Collegium Pharmaceutical, Inc. | 159.2 Million USD | -97.31% |
| Cosmos Health Inc. | 26.18 Million USD | -1099.865% |
| Journey Medical Corporation | 54.59 Million USD | -475.4% |
| Embecta Corp. | 528.4 Million USD | 40.55% |
| Esperion Therapeutics, Inc. | 271.89 Million USD | -15.534% |
| Dynavax Technologies Corporation | 219.14 Million USD | -43.345% |
| Intra-Cellular Therapies, Inc. | 590 Million USD | 46.757% |
| Pacira BioSciences, Inc. | 326.37 Million USD | 3.751% |
| PainReform Ltd. | 9.58 Million USD | -3177.692% |
| Sunshine Biopharma, Inc. | 13.12 Million USD | -2293.499% |
| Sunshine Biopharma, Inc. | 13.12 Million USD | -2293.499% |
| SCYNEXIS, Inc. | 51.84 Million USD | -505.875% |
| Safety Shot Inc | 12.1 Million USD | -2494.071% |
| China SXT Pharmaceuticals, Inc. | 3.06 Million USD | -10135.085% |
| Procaps Group, S.A. | 199.47 Million USD | -57.479% |
| Theratechnologies Inc. | 72.75 Million USD | -331.764% |
| Harrow Health, Inc. | 89.97 Million USD | -249.143% |
| Sonoma Pharmaceuticals, Inc. | 9.44 Million USD | -3225.577% |
| Biofrontera Inc. | 39.95 Million USD | -686.141% |
| DURECT Corporation | 43.71 Million USD | -618.595% |
| Supernus Pharmaceuticals, Inc. | 529.01 Million USD | 40.619% |
| Cronos Group Inc. | 96.7 Million USD | -224.824% |
| OptiNose, Inc. | 85.1 Million USD | -269.126% |
| Ironwood Pharmaceuticals, Inc. | 232.12 Million USD | -35.33% |
| Kala Pharmaceuticals, Inc. | 39.15 Million USD | -702.324% |
| RedHill Biopharma Ltd. | -9.56 Million USD | 3385.577% |
| Guardion Health Sciences, Inc. | 9.73 Million USD | -3128.233% |
| Cumberland Pharmaceuticals Inc. | 43.04 Million USD | -629.856% |
| Radius Health, Inc. | 265.92 Million USD | -18.127% |
| Universe Pharmaceuticals INC | 13.84 Million USD | -2169.441% |
| ProPhase Labs, Inc. | 37.85 Million USD | -729.901% |
| Phibro Animal Health Corporation | 260.29 Million USD | -20.682% |
| Procaps Group S.A. | 187.24 Million USD | -67.766% |
| Alvotech | 285.43 Million USD | -10.053% |
| TherapeuticsMD, Inc. | 9.82 Million USD | -3097.293% |
| Viatris Inc. | 5.96 Billion USD | 94.735% |
| Rockwell Medical, Inc. | 15.37 Million USD | -1943.281% |
| Aytu BioPharma, Inc. | 59.84 Million USD | -424.957% |
| SIGA Technologies, Inc. | 22.04 Million USD | -1325.095% |
| Tilray Brands, Inc. | 251.35 Million USD | -24.975% |
| Lifecore Biomedical, Inc. | 49.03 Million USD | -540.593% |
| Shineco, Inc. | 17.94 Million USD | -1650.241% |
| PetIQ, Inc. | 192.72 Million USD | -62.996% |
| Regencell Bioscience Holdings Limited | 3.99 Million USD | -7770.788% |
| Incannex Healthcare Limited | 30.05 Million USD | -945.267% |
| Neurocrine Biosciences, Inc. | 1.59 Billion USD | 80.324% |
| Alimera Sciences, Inc. | 62.64 Million USD | -401.483% |
| Silver Spike Investment Corp. | 762.49 Thousand USD | -41098.334% |
| Assertio Holdings, Inc. | 368.58 Million USD | 14.773% |
| Shuttle Pharmaceuticals Holdings, Inc. | 5.88 Million USD | -5237.358% |
| Petros Pharmaceuticals, Inc. | 17.8 Million USD | -1663.952% |
| Clever Leaves Holdings Inc. | 21.16 Million USD | -1383.934% |
| Cyclo Therapeutics, Inc. | 21.04 Million USD | -1392.884% |
| Avadel Pharmaceuticals plc | 164.96 Million USD | -90.423% |
| Hempacco Co., Inc. | 7.59 Million USD | -4035.274% |
| Talphera, Inc. | 11.99 Million USD | -2519.093% |
| Alvotech | 285.43 Million USD | -10.053% |
| Eagle Pharmaceuticals, Inc. | 140.71 Million USD | -123.243% |
| Lantheus Holdings, Inc. | 344.9 Million USD | 8.921% |
| Currenc Group, Inc. | 24 Million USD | -1208.778% |
| Kamada Ltd. | 45.42 Million USD | -591.529% |
| Indivior PLC | 911 Million USD | 65.518% |
| Evoke Pharma, Inc. | 12.4 Million USD | -2431.37% |
| Flora Growth Corp. | 10.57 Million USD | -2869.411% |
| Cyclo Therapeutics, Inc. | 21.04 Million USD | -1392.884% |
| Evolus, Inc. | 189.75 Million USD | -65.544% |
| HUTCHMED (China) Limited | 436.23 Million USD | 27.989% |
| Amphastar Pharmaceuticals, Inc. | 154.13 Million USD | -103.806% |
| Akanda Corp. | 3.48 Million USD | -8917.749% |